166 related articles for article (PubMed ID: 34736068)
1. Stimulation and homogenization of the protoporphyrin IX endogenous production by photobiomodulation to increase the potency of photodynamic therapy.
Joniová J; Kazemiraad C; Gerelli E; Wagnières G
J Photochem Photobiol B; 2021 Dec; 225():112347. PubMed ID: 34736068
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
3. Catechin reduces phototoxic effects induced by protoporphyrin IX-based photodynamic therapy in the chick embryo chorioallantoic membrane.
Joniová J; Wagnières G
J Biomed Opt; 2020 Feb; 25(6):1-9. PubMed ID: 32052612
[TBL] [Abstract][Full Text] [Related]
4. Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.
Yang X; Palasuberniam P; Myers KA; Wang C; Chen B
Oncotarget; 2016 Sep; 7(36):57798-57810. PubMed ID: 27527860
[TBL] [Abstract][Full Text] [Related]
5. Reactive Oxygen Species Produced by 5-Aminolevulinic Acid Photodynamic Therapy in the Treatment of Cancer.
Pignatelli P; Umme S; D'Antonio DL; Piattelli A; Curia MC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240309
[TBL] [Abstract][Full Text] [Related]
6. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
7. Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.
Kanick SC; Davis SC; Zhao Y; Sheehan KL; Hasan T; Maytin EV; Pogue BW; Chapman MS
Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):561-6. PubMed ID: 26480810
[TBL] [Abstract][Full Text] [Related]
8. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
[TBL] [Abstract][Full Text] [Related]
9. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis by hexaminolevulinate-mediated photodynamic therapy in human colon carcinoma cell line 320DM.
Shahzidi S; Stokke T; Soltani H; Nesland JM; Peng Q
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):159-71. PubMed ID: 16566715
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry study of the role of superoxide anion and hydrogen peroxide in cellular photodestruction with 5-aminolevulinic acid-induced protoporphyrin IX.
Gilaberte Y; Pereboom D; Carapeto FJ; Alda JO
Photodermatol Photoimmunol Photomed; 1997; 13(1-2):43-9. PubMed ID: 9361128
[TBL] [Abstract][Full Text] [Related]
12. Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells.
Kim CH; Chung CW; Choi KH; Yoo JJ; Kim DH; Jeong YI; Kang DH
Int J Nanomedicine; 2011; 6():1357-63. PubMed ID: 21760730
[TBL] [Abstract][Full Text] [Related]
13. Imaging of hypoxia, oxygen consumption and recovery in vivo during ALA-photodynamic therapy using delayed fluorescence of Protoporphyrin IX.
Scholz M; Petusseau AF; Gunn JR; Shane Chapman M; Pogue BW
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101790. PubMed ID: 32344195
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab-Ag
Hashemkhani M; Demirci G; Bayir A; Muti A; Sennaroglu A; Mohammad Hadi L; Yaghini E; Loizidou M; MacRobert AJ; Yagci Acar H
Nanoscale; 2021 Sep; 13(35):14879-14899. PubMed ID: 34533177
[TBL] [Abstract][Full Text] [Related]
15. Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatment.
Schimanski A; Ebbert L; Sabel MC; Finocchiaro G; Lamszus K; Ewelt C; Etminan N; Fischer JC; Sorg RV
J Photochem Photobiol B; 2016 Oct; 163():203-10. PubMed ID: 27588717
[TBL] [Abstract][Full Text] [Related]
16. Smartphone fluorescence imager for quantitative dosimetry of protoporphyrin-IX-based photodynamic therapy in skin.
Ruiz AJ; LaRochelle EPM; Gunn JR; Hull SM; Hasan T; Chapman MS; Pogue BW
J Biomed Opt; 2019 Dec; 25(6):1-13. PubMed ID: 31820594
[No Abstract] [Full Text] [Related]
17. Identification of excimer delayed fluorescence by Protoporphyrin IX: A novel access to local chromophore concentration?
Croizat G; Gregor A; Joniova J; Gerelli E; Wagnières G
J Photochem Photobiol B; 2022 Apr; 229():112408. PubMed ID: 35294918
[TBL] [Abstract][Full Text] [Related]
18. [5-Aminolevulinic acid esters based photodynamic therapy].
Zhang S; Zhang Z; Jiang D
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jun; 19(2):310-4. PubMed ID: 12224308
[TBL] [Abstract][Full Text] [Related]
19. Cell accumulation and antileishmanial effect of exogenous and endogenous protoporphyrin IX after photodynamic treatment.
Mateus JE; Valdivieso W; Hernández IP; Martínez F; Páez E; Escobar P
Biomedica; 2014; 34(4):589-97. PubMed ID: 25504248
[TBL] [Abstract][Full Text] [Related]
20. Design of Bifunctional Dendritic 5-Aminolevulinic Acid and Hydroxypyridinone Conjugates for Photodynamic Therapy.
Zhou T; Battah S; Mazzacuva F; Hider RC; Dobbin P; MacRobert AJ
Bioconjug Chem; 2018 Oct; 29(10):3411-3428. PubMed ID: 30249090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
